Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 14, 2003
Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening
V A McNally, A Gbaj, K T Douglas, et al.
Planta Medica
|
July 26, 2000
Relaxant and antispasmodic actions of methyleugenol on guinea-pig isolated ileum
C C Lima, D N Criddle, A N Coelho-de-Souza, et al.
Irish Journal of Medical Science
|
May 28, 2011
A re-audit of prevention of venous thromboembolic disease in medical and surgical hospital patients in a single university teaching hospital
M B O'Connor, E O'Sullivan, A Ni Laoire, et al.
Cell Death and Differentiation
|
April 14, 2007
Calcium signalling and pancreatic cell death: apoptosis or necrosis?
D N Criddle, J V Gerasimenko, H K Baumgartner, et al.
International Journal of Biological Macromolecules
|
May 1, 2024
Design, fabrication, and evaluation of keratin and pectin incorporated supramolecular structured zero-oxidation state selenium nanogel blended 3D printed transdermal patch
Chilaka Baburao, Nandakumar Selvasudha, Kunal Kishore, et al.
Biochemical Pharmacology
|
February 29, 2000
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
M P Saunders, M Jaffar, A V Patterson, et al.
Anti-Cancer Drug Design
|
April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro
M Jaffar, M A Naylor, N Robertson, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationships
R M Phillips, M A Naylor, M Jaffar, et al.
Journal of Medicinal Chemistry
|
July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivo
M A Naylor, M Jaffar, J Nolan, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 1999
Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinones
M Jaffar, S A Everett, M A Naylor, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Bioorganic & Medicinal Chemistry Letters
|
October 14, 2003
Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening
V A McNally, A Gbaj, K T Douglas, et al.
Planta Medica
|
July 26, 2000
Relaxant and antispasmodic actions of methyleugenol on guinea-pig isolated ileum
C C Lima, D N Criddle, A N Coelho-de-Souza, et al.
Irish Journal of Medical Science
|
May 28, 2011
A re-audit of prevention of venous thromboembolic disease in medical and surgical hospital patients in a single university teaching hospital
M B O'Connor, E O'Sullivan, A Ni Laoire, et al.
Cell Death and Differentiation
|
April 14, 2007
Calcium signalling and pancreatic cell death: apoptosis or necrosis?
D N Criddle, J V Gerasimenko, H K Baumgartner, et al.
International Journal of Biological Macromolecules
|
May 1, 2024
Design, fabrication, and evaluation of keratin and pectin incorporated supramolecular structured zero-oxidation state selenium nanogel blended 3D printed transdermal patch
Chilaka Baburao, Nandakumar Selvasudha, Kunal Kishore, et al.
Biochemical Pharmacology
|
February 29, 2000
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
M P Saunders, M Jaffar, A V Patterson, et al.
Anti-Cancer Drug Design
|
April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro
M Jaffar, M A Naylor, N Robertson, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationships
R M Phillips, M A Naylor, M Jaffar, et al.
Journal of Medicinal Chemistry
|
July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivo
M A Naylor, M Jaffar, J Nolan, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 1999
Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinones
M Jaffar, S A Everett, M A Naylor, et al.
Page
of 6